EUROAPI generates substantial annual financial turnover operating as a major independent active pharmaceutical ingredient manufacturer, with recent full-year net sales scaling to approximately €848 million (or roughly ₹95.8 billion INR equivalent). Financial results reflect stable industrial manufacturing output, custom contract development manufacturing organization (CDMO) services, and extensive global export deliveries across over 80 countries.